Bodytrak awarded trial contract with US Department of Defense

Courtesy Bodytrak

Bodytrak today announced that the Defense Innovation Unit, through the Army Contracting Command, has awarded Bodytrak a contract to trial its cutting-edge in-ear physiological monitoring technology with US Navy’s fixed wing pilots.

The trial will demonstrate how wearable physiological monitoring technology can help reduce the number of physiological incidents during or after a flight that pose a significant health and safety threat to personnel and contribute to aircrew deaths and aircraft losses. The aim is to prove the benefits of such technology in a controlled environment, deploy pilot tests in flight and accelerate new innovation into the US department of defence - and into the hands of defence personnel.

Bodytrak, which sits unobtrusively in the ear, tracks a range of vital signs accurately and in real time to prevent negative physiological incidents. If an abnormality is detected, an audible alert is provided to the wearer and/or a control centre, acting as an early warning signal to initiate a rapid intervention, resulting in the prevention of a major injury and saving costly resources.

Leon Marsh, CEO and Founder of Bodytrak said: “We are delighted to have been selected as a preferred supplier to the US Department of Defense to trial Bodytrak with the intent of mitigating the present safety risks that fast jet pilots can experience, and provide a key contribution to preventing the associated loss of personnel and aircraft.”